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AIF - Arterial input function 
BD - Binswanger´s disease 
B-waves - A defined type of variation of the intracranial pressure 
CA - Callosal angle  
CBF - Cerebral blood flow 
CNS - Central nervous system 
CSF - Cerebrospinal fluid 
CT - Computerized tomography 
CVR - Cerebrovascular reactivity 
DESH - Disproportionately enlarged subarachnoid space hydrocephalus  
DSC MRI - Dynamic susceptibility contrast magnetic resonance imaging 
DTI - Diffusion tensor imaging 
DWI - Diffusion weighted imaging 
ELD - Extended lumbar drainage 
EPI - Echo planar imaging 
FLAIR - Fluid-attenuated inversion-recovery 
ICP - Intracranial pressure 
iNPH - Idiopathic normal pressure hydrocephalus  
IQR - Interquartile 
M1 – Medial Cerebral artery segment one 
M2 – Medial Cerebral artery segment two 
MRS - Magnetic resonance spectroscopy 
rCBF – Relative cerebral blood flow 
rs - Spearman correlation coefficient 
Rout - Resistance to cerebrospinal fluid outflow 
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Background: Idiopathic normal pressure hydrocephalus (iNPH) is a neurological 
disease characterized by disturbed cerebrospinal fluid dynamics that result in 
ventricular enlargement although the intracranial pressure remains normal. The 
disorder causes gait, balance, cognitive and urinary dysfunction and is one of few 
causes of treatable dementia. More than 80 % of the patients improve clinically after 
neurosurgical treatment with peritoneal- or ventriculo-artrial shunt. However, reliable 
markers for diagnosis and prediction of outcome after shunt surgery are lacking. 
There is a general agreement that cerebral blood flow (CBF) changes play a central 
role in the pathophysiology and in association with clinical symptoms. Perfusion 
patterns that predict good shunt outcome has not yet been identified. 
 
Aim: To investigate whether periventricular perfusion changes, measured with 
magnetic resonance imaging (MRI), can predict the effect of shunt treatment in 
patients with iNPH. 
 
Methods: Prospective, observational study with 24 consecutive patients (median age 
76). The participants were all diagnosed with iNPH according to international 
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guidelines and subjected to shunt surgery. All patients underwent preoperative 
examination of clinical symptoms and a four-month postoperative follow-up. 
Perfusion evaluations were based on regions of interest analysis.  
 
Results: No significant correlation could be found between preoperative 
periventricular CBF and preoperative clinical performance or postoperative clinical 
improvement. The CBF did not differ between shunt treatment responders and non-
responders. However, a linear relationship was observed comparing the pre- and 
postoperative CBF in six patients available (p=0.03). Unexpectedly, comorbidity was 
associated with a poor clinical improvement after shunt treatment (p=0.006).  
 
Conclusion: This study could not show a predictive value of periventricular perfusion 
with regard to outcome after shunt surgery. The results may support our hypothesis of 
a relationship between improved periventricular perfusion and clinical improvement. 
However, statistical power is lacking due to the small sample size. Further studies 
with larger sample sizes are warranted. 
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The cerebral ventricles are connected 
and filled with cerebrospinal fluid 
(CSF) and entitled according to 
position, named first to fourth 
according to their position. The first 
and second ventricle, also known as 
the two lateral ventricles, lie within 
each cerebral hemisphere. Their  Figure 1. Circulation of cerebrospinal fluid (1) 
ventral surface are defined by the basal ganglia, their dorsal surface by the corpus 
callosum and their medial surface by the septum pellucidum. Furthermore, the third 
ventricle form a space in the midline between the left and right thalamus, connecting 
the lateral ventricles through the so called interventricular foramen. The third 
ventricle runs through the midbrain caudally to the cerebral aqueduct which opens 
into the fourth ventricle. This ventricle is positioned between the dorsal side of pons 
and ventral side of cerebellum. It narrows caudally to form the central canal of the 
spinal cord (1). 
Cerebrospinal fluid 
The CSF bears up the weight of the brain and spinal medulla. It also serves as a 
mechanical protection of the central nervous system (CNS) from trauma effects, a 
variable in the intracranial pressure (ICP) regulation and preserves a balanced 
chemical environment for the CNS (2).  
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It is generally believed that the CSF is mainly produced by the choroid plexus, a 
specialized epithelium, located in all ventricles which form an interface between the 
blood line and the CNS (3, 4). The cardiac cycle and rapid respiratory waves promote 
the CSF net flow which circulates from the lateral ventricles through the 
interventricular foramina into the third ventricle and further through the cerebral 
aqueduct into the fourth ventricle. The CSF then passes through the midline aperture 
into the cisterna magna and into the pontine cisterns via the lateral apertures. Some of 
the CSF extend caudally from the basal cisterns into the spinal canal. The remaining 
CSF continues to flow into the subarachnoid space around the brain towards the 
superior sagittal sinus absorbed by specialized structures called arachnoid 
granulations (2). 
 
The normal CSF volume in adults is about 150 ml and the turnover rate is between 
three to five times per day. Aging leads to increased CSF spaces due to loss of brain 
parenchyma, degeneration of the choroid plexa as well as the arachnoid granulations 
and the turnover rate decreases (2). 
Idiopathic normal pressure hydrocephalus (iNPH)  
Idiopathic normal pressure hydrocephalus (iNPH) is a condition of the elderly of 
unknown cause with an idiopathic dilatation of the ventricular system without 
intraventricular obstruction or increased ICP. It is clinically 
characterized by subcortical symptomatology that generates a slowly progressive 
impairment of gait, balance, cognition and continence (5).  
 
Definition, prevalence and incidence 
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The prevalence in Western Europe is around 2 % in adults > 65 year and 6 % > 80 
year (6). The operation incidence is about five surgeries/100 000/year which results in 
an underdiagnosed and undertreated disease (7). 
 
The cause of the normal pressure 
hydrocephalus is considered to be a 
reduction of the cerebrospinal fluid 
absorption to the blood in arachnoid 
granulations in the sagittal sinus and 
along the spinal canal nerve roots. In 
over 50 % of the cases etiology Figure 2. Pathophysiological aspects of iNPH 
remains unknown, therefore called (Courtesy of Prof. Wikkelsø). For abbreviations 
iNPH.  please see page four. 
 
Cerebrovascular risk factors seem to be involved in the pathophysiology of iNPH. 
Jaraj et al (8) proposed that history of hypertension, diabetes mellitus and white 
matter lesions are related to clinical and imaging features. Israelsson et al (9) support 
this hypothesis claiming that vascular risk factors and vascular diseases contribute to 
the development of iNPH. Additionally, there is a general agreement that reduced 
cerebral blood flow (CBF) plays a central role in the pathophysiology of iNPH. 
Studies have shown that subcortical hypoperfusion, especially in the periventricular 
tissue, is an important contributor (2). The subcortical impact of CBF changes 
correspond to the subcortical clinical picture (10) but the relationship between the 
perfusion level and the severity of clinical features of iNPH is not clarified (2).  
Pathophysiology 
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Cerebral changes connected to normal aging, the overrepresentation of 
cerebrovascular disease and vascular risk factors and the coexistence of other 
disorders, for instance Alzheimer´s disease, complicate understanding of the disease 
process (11). Figure 2, created by Professor Carsten Wikkelsø, illustrates potential 
pathophysiological mechanisms. 
 
The remaining cases of NPH, called secondary normal pressure hydrocephalus, result 
from circumstances such as subarachnoid bleeding, head injury, infections or 
neurosurgery. 
 
iNPH occurs in adults at all ages but it is most common in 65-75 year-olds. Men and 
women are equally affected (12). The first symptom of iNPH is often disturbance of 
gait illustrated as hypokinetic, short broad-based steps with low foot-floor elevation, 
outward rotation of the toes and occasional freezing (13, 14). Other motor functions 
are also impaired which can cause for example brady- and hypokinesia of the face and 
upper extremities (15, 16). 
 
Imbalance and postural difficulties are often experienced as a tendency to lean or fall 
backwards. This is related to an abnormal subjective visual vertical perception (17). 
iNPH patients often demonstrate emotional-motivational problems such as emotional 
indifference, lack of drive and apathy and/or somnolence-sopor-coma disorder 
characterized by for example impaired wakefulness. Among some patients an 
astheno-emotional disturbance with fatigue, memory- and concentration difficulties 
and irritability occur. Patients often experience memory disturbance (18). 
Clinical picture 
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Lower urinary tract symptoms such as urinary urgency, incontinence and increased 
frequency of urination generally develop later than other symptoms in iNPH patients, 
or not at all. Incontinence and urinary frequency are the main lower tract symptoms 
(LUTS) which most likely derive due to detrusor hyperreflexia (19). 
 
Important differential diagnostic diseases are Binswanger´s disease, atypical 
Parkinson´s disease for example Progressive Supranuclear Palsy and Alzheimer´s 
disease due to clinical and radiological similarities such as central atrophy with 
dilatation of the ventricular system. 
 
The diagnosis of iNPH is confirmed after a clinical evaluation, neuroimaging and a 
physiological data investigation. The European-American guidelines are often used 
for diagnostic criteria (20), summarized in table 1. 
The general impairment in iNPH patients pre- and postoperative can be graded by a 
number of clinical scales. Hellström et al (21) proposed a new scale in an attempt to 
standardization, where the clinical performance of iNPH patients is estimated in four 
domains which illustrate the most characteristic features of the disease – gait, balance, 
neuropsychology and continence – as well as in total.  
 
Imaging of iNPH is mainly performed by brain computerized tomography (CT) and 
magnetic resonance imaging (MRI). MRI is superior to CT as it provides more 
information of diagnostic relevance and avoids exposure to ionizing radiation. In 
addition, MRI is a better method for detecting white matter changes, for identification 
of non-communicating cases and for examination of CSF flow. Imaging criteria are 
Clinical investigation 
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shown in table 1. Evan´s index is used to differentiate normal and enlarged ventricular 
size in iNPH patients (>0.3) which defines the ratio of the widest diameter of the 
frontal horns to the widest diameter of the brain on the same axial slice (20). Further 
changes that point toward an iNPH diagnosis are periventricular white matter 
changes, dilated temporal horns, dilated third ventricle and no cortical atrophy.  
 
The callosal angle (CA), the angle between the lateral ventricles viewed on a coronal 
image, is considered to be a diagnostic tool. In individuals without iNPH the angle is 
between 100-120° whereas in patients with iNPH it is 50-80° (22). Furthermore, 
disproportionately enlarged subarachnoid space hydrocephalus (DESH) can also be a 
useful tool when diagnosing iNPH (23).  
 
Table 1. Summary of diagnostic criteria of iNPH according to the European-American guidelines (20). 
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A current method to predict the possible shunt effect is to investigate the CSF 
dynamics, preferably by a so called Spinal Tap Test which simulates shunting or by a 
Cerebrospinal Fluid Dynamic Test. A positive Spinal Tap Test result means that the 
patient shows significant clinical improvement when 40-50 ml of CSF are withdrawn 
(24). Transient improvement – hours and occasionally days – predict clinical 
improvement after shunt surgery. The CSF Dynamic Test registers the resistance 
against infusion of artificial CSF via lumbar puncture. These supplementary tests that 
gives physiological data could increase the prognostic accuracy to more than 90 % 
(12). However, a negative response to the test does not necessarily mean that the 
patient is unqualified for shunt treatment (25). Using these tests for selection of 
patients for shunt surgery would therefore result in exclusion of many patients who 
would benefit from the treatment. 
 
As previously stated, iNPH is underdiagnosed possibly due to the fact that symptoms 
and imaging findings can be confused with “normal aging” or mistaken as other 
neurological conditions, for instance Alzheimer´s disease (18, 19). iNPH is a 
reversible neurological disorder and one of few causes of treatable dementia. More 
than 80 % of the patients improve three months after neurosurgical treatment with 
peritoneal- or ventriculoatrial shunt which leads CSF from the ventricles to the 
peritoneal cavity (26). If contraindications for intraventricular shunts occur, a 
lumboperitoneal shunt can be used. A ventriculopleural shunt is considered when no 
other options remain. 
 
Treatment 
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iNPH is undertreated probably due to the difficulties in estimating benefits of the 
surgical procedure in relation to the risks (27, 28). Comorbidity, coagulation and 
immune status, age and clinical performance may influence the benefit-to-risk ratio 
negatively. The percentage of improved patients at three months and one year has 
since 2006 increased to more than 80 % and mortality rate have decreased to 0.2 %. 
Long-term effects are favorable with more than 70 % improved patients after five 
years in later studies (29). These results may be a consequence of improved hospital 
care as well as rehabilitation. Furthermore, the benefit-to-risk analysis and developed 
use of supplementary tests might have commenced better selection of patients (2). 
 
Among those who are candidates for surgery there are still no routine to know who 
will respond from shunt treatment. Therefore it is important to find better methods to 
identify responders and non-responders. 
 
Aim  
This study is part of a research project initiated in 2014. The overall purpose of the 
project is to identify MRI- and CSF markers that predict the shunt treatment effect of 
iNPH patients and to hopefully introduce these results in the clinical routine.  
 
The primary aim of this study was to test the hypothesis that preoperative perfusion in 
the bilateral frontal periventricular white matter, measured with MRI, can predict the 
effect of shunt treatment in patients with iNPH. Specific research questions were; 1) 
Can preoperative perfusion identify shunt responders from non-responders?; 2) Is 
there a linear relationship between preoperative perfusion and outcome after shunt 
treatment? 
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The secondary aim was to investigate the associations between frontal periventricular 
perfusion changes and postoperative clinical improvement.  
 
Material and Methods 
The current study is a part of a larger collaboration project between Sahlgrenska 
University Hospital, Gothenburg University and Östersund Hosptial, Umeå 
University. It is a prospective, blinded observation study including 152 patients 
diagnosed with iNPH according to American-European guidelines (20, 30) during the 
period 140101-160630 and subjected to shunt surgery. Diagnosis was based on 
clinical symptoms, physiological data and characteristic MRI. If the outcome of shunt 
surgery was considered uncertain preoperatively, often due to indistinct or atypical 
symptomatology, the CSF tap test (31) was used as supplementary test to support the 
indication for shunt surgery. Only those patients presenting a positive tap test were 
subjected to surgery. A lumbar puncture was performed preoperatively and all 
patients had a normal ICP (< 18 mm Hg). 
 
All patients underwent a pre- and four-month postoperative investigation. Symptoms 
and signs were scored on the iNPH scale (21) at the NPH center of Sahlgrenska 
University Hostpital by an experienced neurologist, neuropsychologist and 
physiotherapist. Performance was evaluated in the four domains of gait, balance, 
neuropsychology and continence resulting in a total score from 0 to 100, where 100 
represents normal performance and 0 maximal symptom burden, both pre- and four-
month postoperatively. Participants were classified into shunt responders and non-
responders based on an arbitrary chosen limit on the iNPH scale representing a clear 
clinical improvement (21). Improvement was defined as an increase of ≥5 points of 
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the total score (responders) and <5 points of the total score was defined as poor 
outcome (non-responders). The improvement corresponded to an increase in the 
domains - 12.5 points in the gait domain or 25 points in one of the remaining domains 
balance, continence and neuropsychology. 
 
All patients received a ventriculo-peritoneal shunt with a Strata™ Valve (Medtronic 
PS Medical, Santa Barbara, USA) and an anti-siphon device. All shunts were working 
at the four-month postoperative evaluation.  
Clinical aspects 
In this study, 101 of the 152 patients were primarily included due to time limitation of 
the project. Furthermore, 77 patients were excluded as shown in figure 3.   
  
Figure 3. Flow Chart on number of patients excluded in the current study. 
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Thus, 24 patients, 20 male (83 %) and 4 female (17 %), median age at operation 76 
years ranging from 58-91 years was further analyzed. Median disease duration was 24 
months. Diabetes, hypertension and/or cardiovascular disease was present in 16 
patients (67 %). Clinical demographics are summarized in table 2. 
 
Table 2. Demographic data of the studied group. 
 
IQR = interquartile range; Comorbidity = at least one of described conditions; CVD = cardio 
vascular disease. 
Imaging 
The brain was imaged pre– and four months postoperatively with a 1.5T Gyroscan 
Intera 9.1 system (Philips Medical Systems, Best, The Netherlands) using an 
eight-channel sense head coil. The morphological scan protocol included a transverse 
fluid-attenuated inversion-recovery (FLAIR) sequence (TE 100 milliseconds, TR 
9000 milliseconds, IR delay 2500 milliseconds, slice thickness 3 millimeter, no slice 
gap, 48 slices, FOV 230 millimeter, image acquisition matrix 192×145 reconstructed 
to 256×256) covering the entire brain. DSC MRI perfusion images were obtained 
each 1000 milliseconds with a segmented k-space gradient-echo echo planar imaging 
(EPI) technique (TE 30 milliseconds, TR 500 milliseconds, flip angle 40o , slice 
thickness 6 millimeter, no slice gap, 18 slices, FOV 230 millimeter, matrix 128 x 64, 
parallel imaging: SENSE factor 2). Using a power injector, a rapid bolus (5 
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milliliter/second) of 0.1 millimolar/kilogram body weight gadoterate meglumine 
(279.3 milligram/milliliter, Dotarem, Gothia Medical) was initiated at the 10th 
acquisition and administered through a 20–gauge IV line into the right antecubital 
vein, followed by a saline flush.  
Data review 
Clinical patient data were manually registered and introduced into a research 
database. Preparation of protocol for the analysis of perfusion in regions of interest 
(ROI) were made in several steps. The MRI studies were visually examined with 
regard to movement artifact, the ventricle shunt position, extent of the associated 
metal artifacts and the overall quality of the investigation. Thereafter the MRI surveys 
were registered and cataloged in the database based on quality and suitability for 
further image analysis. The material was unidentified and encoded according to a 
study code. Basic image processing was performed with window setting according to 
standard in-house protocols and documentation of selected windows. The data were 
manually registered and introduced into the research database.  
Regions of interest 
An anatomical region that has been shown to be engaged in NPH (10, 32, 33) 
determined the choice of ROI in this study – the anterior periventricular white matter 
– and reference ROI were drawn in the cerebellum to maintain a normalized relative 
CBF value.  
 
The anterior periventricular white matter ROIs were drawn bilaterally, three to five 
millimeter wide, depicting the anterior horns of the lateral ventricles (usually in four 
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to five slices). The medial border of the anterior cap-like ROI was the lateral border 
of the cingulate sulcus and its lateral/dorsal border the head of the caudate nucleus. 
 
Figure 4. Description of Region of interest (ROI) placement: A) Anterior periventricular white matter, 
dexter and sinister; B) Arterial Input Function (AIF) - necessary for perfusion parameter extraction; 
C) Reference in cerebellum - hemispheres; D) Reference in cerebellum – vermis. 
 
The cella media represented the cranial border. The anterior periventricular ROIs 
were positioned in the same manner regardless of the macroscopically appearance of 
the white matter in this region, as it has been shown that periventricular and deep 
white matter heterogeneities are similar in patients with NPH and Binswanger disease 
(BD) (11). In preoperative data, the mean perfusion value of the right and left ROI 
was used as the preoperative perfusion in further analysis (see below). Due to the 
right sided shunt artefact postoperative perfusion could not be obtained in the right 
periventricular region. Hence, the perfusion value of the left ROI was used for 
A B 
C D 
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assessing postoperative perfusion and compared with the left preoperative ROI when 
assessing postoperative perfusion changes. 
 
The reference ROI in cerebellum, round and approximately three centimeters in 
diameter, were positioned in three adjacent slices centrally in each cerebellar 
hemisphere, covering both grey and white matter structures. Due to limited perfusion 
data in some patients, another reference ROI were manually drawn around the vermis 
area, in approximately three slices, if a reference ROI in each hemispheres could not 
be achieved. 
 
Arterial input function (AIF) necessary for perfusion parameter extraction was drawn 
along the middle and distal part of the middle cerebral artery segment one (M1) and 
along the proximal middle cerebral artery segment two (M2). The artery was followed 
in two succeeding sections in the left hemisphere.  
Post processing 
Voxels within each ROI were averaged at each time point to form one signal time 
curve for every ROI. This curve was analyzed with an algorithm in the intent to 
quantify the perfusion. The mathematical process requires an "arterial input function" 
(AIF), which represents a dynamic time curve of the contrast agent injection into the 
ROI. 
 
By tradition, the choice of AIF is manually performed and voxels that have a steep, 
narrow and high concentration-to-time curve are selected. This requires time and 
AIF selection 
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since there are many voxels for the operator to choose from, different operators may 
not select voxels in the exact same way. Even the same operator may choose diverse 
AIF on the same dataset on two different occasions. Therefore it is suitable to use 
automatic or semi-automatic methods that select the most suitable voxels according to 
these criteria. 
 
An in-house-developed and semiautomatic algorithm based on Mouridsen (34) was 
used to extract the AIF. The operator specifies a ROI that includes the artery of 
interest and the algorithm extracts an AIF from the subset of voxels within the ROI. 
This differs from the method described by Mouridsen where the algorithm selects 
voxels from the entire brain (34). 
 
As previously stated, the tissue residue curve which can be used to extract the 
perfusion parameters is found by de-convolving the measured data with the AIF. For 
this procedure we used an in-house-developed Fourier deconvolution algorithm (35). 
The deconvolution results in a tissue residue function in which the CBF can be 
extracted.  
 
In order to compare perfusion across subsets the perfusion values were normalized to 
perfusion estimates of a reference ROI. The CBF estimate of the ROI in the anterior 
periventricular white matter was divided by the CBF value of the internal reference 
ROI in the cerebellum creating a relative CBF value (rCBF). Preoperative perfusion 
data were available in all 24 patients; both pre- and postoperative perfusion data in 
six. 
Deconvolution and normalization 
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Since data were not normally distributed, nonparametric tests were used. To analyze 
changes over time (paired data), Wilcoxon´s signed ranks test for related samples was 
used. The Spearman rank correlation test was used to explore correlations. Mann 
Whitney U test was used to assess differences between independent groups. All 
significance tests were two-tailed and P < 0.05 was set as significant. All analyses 
were performed with IBM SPSS 24.0 for Windows. 
 
Ethics 
The study is approved by the Research Ethics Committee and all included patients or 




Clinical performance improved after shunt treatment (p=0.000094). The median 
preoperative iNPH score was 54 ± 33 (Interquartile range, IQR) with a range between 
34-81 points. Median postoperative improvement was 10 ± 15 (IQR) with a range 
between -9-39 points (p<0.001). Clinical characteristics of the 18 (75 %) improved 
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Table 3. Demographic data and clinical outcome of improved and non-improved patients. 
 
IQR = interquartile range; Comorbidity = at least one of described conditions; CVD = cardio 
vascular disease; iNPH score = preoperative clinical performance measured by the NPH scale (21); 
PiNPH = postoperative clinical performance measured by the NPH scale (21). 
 
Associations between frontal periventricular CBF and clinical 
symptoms and outcome after shunt treatment 
The median preoperative rCBF (n=24) was 0.4 (mL/100g/min, range 0.2-0.6). In the 
six patients with available postoperative perfusion data, the median rCBF increase 
was 0.09 (mL/100g/min). 
 
The preoperative rCBF did not correlate with the preoperative iNPH scale score (rs=-
0.04, p=0.85). There was no correlation found between the preoperative rCBF and 
postoperative improvement on the iNPH scale visualized in figure 5 (rs=0.06, 
p=0.77). Preoperative rCBF did not differ between improved or unimproved patients 
(p=0.97) viewed in figure 6. The rCBF improved after shunt treatment (p=0.03). The 
postoperative increase in rCBF is plotted against postoperative clinical improvement 
in figure 7 but did not show a significant correlation (rs=0.60, p=0.21).  
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Figure 5. Preoperative rCBF (PreoperativePerfusion) in relation to clinical outcome on the NPH scale 
(n=24). Green line represents cutoff value for clinical improvement. 





Figure 6. Preoperative rCBF (PreoperativePerfusion) in clinically not improved (n=6) and improved 
(n=18). 
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Figure 7. Postoperative increase in rCBF in relation to clinical improvement (n=6). 
DInphTot = clinical improvement in points measured on the NPH scale (21); DPerfusion = rCBF 
improvement after shunt surgery measured by MRI perfusion. 
Influence of vascular comorbidity on perfusion and clinical 
improvement 
Patients with vascular comorbidity did not have significantly different preoperative 
rCBF compared to those without (p=0.23) visualized in figure 8. Patients with 
vascular comorbidity had a worse clinical outcome (median 7.8, IQR 15.9) than those 
without (median 17.7, IQR 23.3) (p=0.021). 
 
Figure 8. Preoperative rCBF (PreoperativePerfusion) in participants with (n=16) or without (n=8) 
comorbidity. 
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Description of the study and Main findings 
This prospective, observational study including 24 patients provides comprehensive 
data on preoperative clinical presentation, clinical outcome after shunt treatment, 
comorbidity and preoperative perfusion. Our primary aim was to investigate whether 
MRI perfusion imaging of the brain can predict the effect of shunt treatment in 
patients with iNPH. All participants were evaluated pre- and postoperatively 
regarding clinical performance and preoperative perfusion in a region of interest – 
anterior periventricular white matter. Eighteen patients (75 %) improved clinically (≥ 
5 point on the iNPH scale) whereas six patients (25 %) did not improve (< 5 point on 
the iNPH scale) after shunt treatment. No correlation could be found between 
preoperative perfusion and preoperative performance or postoperative clinical 
improvement. The periventricular perfusion increased postoperatively in the six 
patients where postoperative perfusion could be assessed. 
Clinical aspects 
The study population (n = 24) were diagnosed with iNPH according to European-
American guidelines (20). Clinical data were consecutively collected, converted to 
continuous data. The minor group size and the selection of individuals to which the 
iNPH disease contributes resulted in not normally distributed data. Participants were 
classified into improved and not improved based on an arbitrary chosen limit on the 
iNPH scale (21). The distribution of outcome rates, i.e. 75% responders (n=18) and 
25% non-responders (n=6), is within the expected range (29), which indicates that the 
chosen limit is consistent with the limits of other, previously used scales.  
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Interestingly, the median duration of symptoms was shorter and the preoperative 
clinical performance better in the non-responder group compared with the responders 
group. Responders were also slightly older than non-responders. The inverse 
relationship is expected considering that iNPH is a progressive disease. However, the 
distribution of these clinical variables might be explained by a combination of the 
small size of the non-responder group and the large inter-individual variability of the 
natural course of iNPH (36). 
Perfusion data 
To evaluate the perfusion, ROIs were drawn in anatomical regions that previous 
studies have proposed to be engaged in NPH (10, 32, 33). In this project we studied 
the anterior periventricular white matter and a reference ROI were drawn in 
cerebellum to maintain a relative perfusion value for normalization.  
A majority of the cerebellar perfusion data were limited and could not correlate with 
the processed FLAIR imaging data in which the ROIs were drawn. This resulted in 
limited data to analyze which explain the extent of excluded patients.  
 
Preoperative perfusion was calculated as a mean value based on bilateral data from 
both right and left hemisphere. Postoperative perfusion analysis was limited due to 
shunt artifact in the right hemisphere. Hence, unilateral postoperative data assessed 
from the left hemisphere was analyzed but since bilateral perfusion changes are 
expected, this was not considered as a limitation. In spite of the small sample size and 
limitations described above, we believe that perfusion estimates are valid and 
representable.  
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In agreement with previous studies (12) postoperative clinical performance was 
significantly improved compared to preoperative clinical performance. No correlation 
was found between preoperative perfusion and preoperative clinical performance. In 
contrast with previous studies (37) the preoperative perfusion did not correlate with 
the clinical improvement. Preoperative perfusion could not be used to differentiate 
between improved and non-improved patients. These results may be explained by, 
apart from the small sample size. However, other factors related to the iNPH state 
may affect the clinical outcome, e.g. biochemical changes in the periventricular white 
matter. It is possible that the combined use of MR perfusion and CSF biomarkers may 
prove a better tool to predict reversibility (38). 
 
A significant result was found comparing the pre- and postoperative perfusion. This 
corroborates with previous findings (37, 39) and confirms that this region is involved 
in the pathophysiology. Despite small sample we believe these results are valid. The 
increase of postoperative perfusion and the clinical improvement after shunt treatment 
did not correlate at a significant level. However, the Spearman correlation coefficient 
was 0.6 and the plot (figure 7) may indicate a linear relationship. This is in line with 
previous studies where a reversed condition in iNPH patients correlates with an 
improved perfusion (33, 40). Our result may be explained, as mentioned above, by the 
minor sample size. Larger sample sizes are needed to increase the power of these 
investigations.  
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Surprisingly, patients with vascular comorbidity had a worse clinical outcome 
compared to those without. However, previous studies have shown that the presence 
of cerebrovascular risk factors do not predict negative shunt treatment outcome (41).  
Main limitations 
There are several important limitations that should be considered and discussed. One 
main limitation is that the current study consisted of a small sample size because of 
inadequate MRI surveys and limited cerebellar perfusion data. This may cause falsely 
negative results due to lack of statistical power. Differences in gender distribution 
should also be recognized, nevertheless, we believe that our results are valid. Another 
limitation is that the ROI-analysis are to some degree operator dependent and in this 
study only one operator placed all ROIs which may affect the intra-observer 
reliability.  
 
Furthermore, our study indicate a possible association between vascular comorbidity 
and outcome after surgery. Again, the small sample size may lead to incorrect 
significant associations. Further prospective studies are required to confirm the effects 
of perfusion as a predictor of treatment outcome.  
 
The choice of cerebellum as an internal reference instead of the occipital cortex, used 
in previous studies (2), were done considering future clinical implementation. A ROI 
in cerebellum is easily prepared whereas the occipital ROI is much more complicated 
to perform. However, the limited cerebellar perfusion data restricted the possibility to 
evaluate cerebellum as a reference ROI. Nevertheless, perfusion values based on 
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available reference material were observed to be as expected along with perfusion 
improvement. 
Main strengths 
The main strengths of this thesis is the well examined and well diagnosed patients. 
Participants were consecutively collected and the clinical data are reliable, collected 
at one center and inter-professionally performed by a neuropsychologist, a 
physiotherapist and a neurologist. As previously stated, only one operator placed all 
ROIs which may not only be a limitation but also a strength due to the fact that 
collected ROI data might be similar and therefore more likely comparable. 
Furthermore, the process which extracted the perfusion parameters from the measured 
data was a valid and earlier published method (42). 
Scientific and clinical value 
This study evaluated the utility of perfusion in the anterior periventricular white 
matter for prediction of prognosis after shunt treatment in iNPH patients. However, 
our study could not show predictive perfusion measurement in the selection of shunt 
candidates shared with other adjunctive tests and do not exceed what can be 
accomplished by an interdisciplinary expert team. Further studies are warranted and 
larger sample sizes of both responders and especially non-responders are needed to 
increase the power of these investigations. 
Conclusion 
In this study, preoperative perfusion did not correlate with preoperative clinical 
performance or clinical improvement. This indicates that preoperative perfusion could 
not identify shunt responders from non-responders in patients with iNPH. However, a 
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significant result was found comparing the pre- and postoperative perfusion with a 
possible association to clinical improvement. Interestingly, presence of vascular 
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Användning av MR perfusion för att prediktera behandlingseffekt 
hos patienter med idiopatisk normaltryckshydrocephalus 
Idiopatisk normaltryckshydrocefalus (iNPH) är en neurologisk sjukdom 
karakteriserad av gång- och balanssvårigheter, nedsättning av intellektuella funktioner 
och vattenkastningsbesvär samt kommunicerande vidgning av hjärnans hålrum 
(ventriklar) och normalt intrakraniellt tryck. Diagnostiken baseras på en kombination 
av typiska symptom, karakteristiska fynd på CT eller MR av hjärnan och 
ryggvätskeundersökning. Tillståndet behandlas med en ventrikuloperitoneal- eller 
ventrikuloatrial likvorshunt vilket leder till förbättring hos ca 80 %. Trots goda 
behandlingsresultat med neurokirurgisk operation finns ännu inga tydliga objektiva 
metoder för att säkert förutspå behandlingseffekt och behovet av sådana metoder är 
stort.  
 
Den primära målsättningen för vår aktuella studie var att utforska hypotesen om 
avbildning av blodflödet i hjärnan, mätt med DSC MRI, kan prediktera effekten av en 
shuntoperation hos patienter med iNPH. Detta är av medicinsk relevans då iNPH är 
ett behandlingsbart tillstånd och en av få orsaker till behandlingsbar demens samt att 
man vill motverka att patienter som inte får goda behandlingsresultat av shunt inte ska 
genomgå operation med tanke på de risker detta medför.  
 
Inklusionskriterier för studien var patienter som efter utredning erhållit diagnosen 
iNPH enligt internationella riktlinjer samt erbjudits och tackat ja till operation.  
Bakgrund 
Aktuell studie 
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152 patienter inkluderades under perioden 2014-01-13 – 2016-06-30. Klinisk 
undersökning med kvantifiering av symtom, MR hjärna samt ryggvätskeundersökning 
utfördes före och fyra månader efter operation.  
 
Anatomiska regioner i hjärnan med påverkat blodflöde som i tidigare studier visat sig 
vara engagerade vid iNPH var avgörande för val av region av intresse (ROI). I denna 
studie tittade vi framför allt på anterior periventrikulär vit substans med referens från 
vävnad i lillhjärnan. 
 
Studien är godkänd av forskningsetisk kommitté och alla inkluderade patienter har 
lämnat skriftligt samtycke till deltagande. 
 
24 patienter studerades med avseende på klinisk förbättring och blodflöde i specifika 
regioner i hjärnan. 18 patienter (75 %) förbättrades kliniskt medan sex patienter (25 
%) inte förbättrades kliniskt efter shuntoperation. 
 
Studien kunde inte visa på någon korrelation varken mellan blodflöde i anterior 
periventrikulär vit substans före operation och klinisk prestation före operation eller 
mellan blodflöde före operation och klinisk förbättring efter operation. Studien fann 
däremot ett signifikant resultat vid jämförelse mellan förbättring av blodflöde i 
samma område före och efter operation (p=0.03). Oväntade resultat visade också att 
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Studien kunde inte påvisa ett prediktivt värde av blodflödet i anterior periventrikulär 
vit substans. Studieresultaten styrker i viss mån vår hypotes om att förändrat 
blodflöde i denna del av hjärnan är kopplat till centrala sjukdomsmekanismer samt 
eventuellt kan prediktera effekten av en shuntoperation hos patienter med iNPH. Då 
studien baseras på en liten studiepopulation kan resultaten vara missvisande på grund 
av låg statistisk styrka. Större studiepopulationer av både respondenter och framför 


















Diskussion och konklusion 
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